The potential of the emerging Glucagon-like Peptide-1 (GLP-1) Agonists in changing the current clinical practice guidelines is crucial to analyze, especially when it comes to real-world scenarios
The co-formulation of semaglutide with SNAC (marketed as Rybelsus) was approved by the FDA in September 2019 for type 2 diabetes at doses of 3 mg, 7 mg, and 14 mg once daily
This happens because of a gas called hydrogen sulphide (H2S)
Be clear about your goals: "I am taking [Medication Name] for weight loss, but I want to ensure my thyroid function is supporting my metabolism properly
For nutrition, focus on whole foods rich in protein, fiber, and healthy fats, the exact nutrients that naturally stimulate GLP-1 production
Adapting to a change in medication will often interrupt a patients weight-loss trajectory, she said, and the trial-and-error could create a lot of waste for medications that were in shortage not long ago